Yasunori “Yaz” Ishibashi, Pharm.D.
General manager of the Animal Health Science Department at Tokyo-based Sumitomo Corporation, Yasunori Ishibashi brings 29 years of experience to Piedmont Pharmaceuticals. Specializing in pharmaceutical business development, Ishibashi has held positions at Sumitomo offices in both Japan and the United States. Ishibashi serves on the boards of Chinese animal health company Shandong Sinder Technology plus Summit Agro International, a trading company specializing in chemicals and materials for agriculture, environmental health, and pet care products. A licensed pharmacist, Ishibashi graduated from the Graduate School of Pharmaceutical Sciences at Tohoku University.
Founded over 400 years ago, Sumitomo is a diversified global trading and business investment company with 136 locations in 66 countries or regions. Ranked in the Fortune Global 500 for 25 years, the entire Sumitomo group includes over 950 associated companies and subsidiaries with more than 72,000 personnel. Sumitomo’s core business areas include Metal Products, Transportation and Construction Systems, Infrastructure, Media and Digital, Living Related and Real Estate, and Mineral Resources, Energy, Chemical and Electronics. Sumitomo Corporation is the only Japanese integrated trading company with a department dedicated to veterinary medicine.